These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38453543)

  • 61. Pramipexole reduces phosphorylation of α-synuclein at serine-129.
    Chau KY; Cooper JM; Schapira AH
    J Mol Neurosci; 2013 Oct; 51(2):573-80. PubMed ID: 23681749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Extracellular α-synuclein levels are regulated by neuronal activity.
    Yamada K; Iwatsubo T
    Mol Neurodegener; 2018 Feb; 13(1):9. PubMed ID: 29467003
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.
    Elsholz L; Wasser Y; Ziegler P; Habib P; Voigt A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831053
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of alpha-synuclein post-translational modifications on metal binding.
    González N; Arcos-López T; König A; Quintanar L; Menacho Márquez M; Outeiro TF; Fernández CO
    J Neurochem; 2019 Sep; 150(5):507-521. PubMed ID: 31099098
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serine 129 phosphorylation of membrane-associated α-synuclein modulates dopamine transporter function in a G protein-coupled receptor kinase-dependent manner.
    Hara S; Arawaka S; Sato H; Machiya Y; Cui C; Sasaki A; Koyama S; Kato T
    Mol Biol Cell; 2013 Jun; 24(11):1649-60, S1-3. PubMed ID: 23576548
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
    Lee KW; Chen W; Junn E; Im JY; Grosso H; Sonsalla PK; Feng X; Ray N; Fernandez JR; Chao Y; Masliah E; Voronkov M; Braithwaite SP; Stock JB; Mouradian MM
    J Neurosci; 2011 May; 31(19):6963-71. PubMed ID: 21562258
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alpha-synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease.
    Chen L; Feany MB
    Nat Neurosci; 2005 May; 8(5):657-63. PubMed ID: 15834418
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neuronal inclusions of α-synuclein contribute to the pathogenesis of Krabbe disease.
    Smith BR; Santos MB; Marshall MS; Cantuti-Castelvetri L; Lopez-Rosas A; Li G; van Breemen R; Claycomb KI; Gallea JI; Celej MS; Crocker SJ; Givogri MI; Bongarzone ER
    J Pathol; 2014 Apr; 232(5):509-21. PubMed ID: 24415155
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies.
    Sengupta U; Guerrero-Muñoz MJ; Castillo-Carranza DL; Lasagna-Reeves CA; Gerson JE; Paulucci-Holthauzen AA; Krishnamurthy S; Farhed M; Jackson GR; Kayed R
    Biol Psychiatry; 2015 Nov; 78(10):672-83. PubMed ID: 25676491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.
    Rey NL; George S; Steiner JA; Madaj Z; Luk KC; Trojanowski JQ; Lee VM; Brundin P
    Acta Neuropathol; 2018 Jan; 135(1):65-83. PubMed ID: 29209768
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sensing α-Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration.
    Brás IC; Lopes LV; Outeiro TF
    Mov Disord; 2018 Nov; 33(11):1675-1684. PubMed ID: 30423195
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development and characterization of polo-like kinase 2 loaded nanoparticles-A novel strategy for (serine-129) phosphorylation of alpha-synuclein.
    Rodríguez-Nogales C; Garbayo E; Martínez-Valbuena I; Sebastián V; Luquin MR; Blanco-Prieto MJ
    Int J Pharm; 2016 Nov; 514(1):142-149. PubMed ID: 27863657
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.
    Prieto Huarcaya S; Drobny A; Marques ARA; Di Spiezio A; Dobert JP; Balta D; Werner C; Rizo T; Gallwitz L; Bub S; Stojkovska I; Belur NR; Fogh J; Mazzulli JR; Xiang W; Fulzele A; Dejung M; Sauer M; Winner B; Rose-John S; Arnold P; Saftig P; Zunke F
    Autophagy; 2022 May; 18(5):1127-1151. PubMed ID: 35287553
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pathological biochemistry of alpha-synucleinopathy.
    Iwatsubo T
    Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay.
    Arlinghaus R; Iba M; Masliah E; Cookson MR; Landeck N
    J Parkinsons Dis; 2023; 13(2):255-270. PubMed ID: 36847016
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
    Anderson JP; Walker DE; Goldstein JM; de Laat R; Banducci K; Caccavello RJ; Barbour R; Huang J; Kling K; Lee M; Diep L; Keim PS; Shen X; Chataway T; Schlossmacher MG; Seubert P; Schenk D; Sinha S; Gai WP; Chilcote TJ
    J Biol Chem; 2006 Oct; 281(40):29739-52. PubMed ID: 16847063
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
    Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
    Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization.
    Samuel F; Flavin WP; Iqbal S; Pacelli C; Sri Renganathan SD; Trudeau LE; Campbell EM; Fraser PE; Tandon A
    J Biol Chem; 2016 Feb; 291(9):4374-85. PubMed ID: 26719332
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.
    McCormack AL; Mak SK; Shenasa M; Langston WJ; Forno LS; Di Monte DA
    J Neuropathol Exp Neurol; 2008 Aug; 67(8):793-802. PubMed ID: 18648323
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.